Niki BioSolutions, Inc. Marketable Securities, Gain (Loss)
Niki BioSolutions, Inc. (NIKI) reported Marketable Securities, Gain (Loss) of $192.13 thousand for the 6-month period ending 2020-06-30, per its 6-K filed 2020-09-02.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2020-09-02
| Period end | Marketable Securities, Gain (Loss) 6 month | Marketable Securities, Gain (Loss) 10 month | Marketable Securities, Gain (Loss) 12 month |
|---|---|---|---|
| 2020-06-30 | $192.13K 6-K · filed 2020-09-02 | ||
| 2019-12-31 | -$81.84K 20-F · filed 2020-04-29 | ||
| 2019-06-30 | $315.98K 6-K · filed 2020-09-02 | ||
| 2018-12-31 | $501.52K 20-F · filed 2020-04-29 | ||
| 2017-12-31 | $3.91M 20-F · filed 2020-04-29 |